CMS to require NPI numbers in January - CMS to require NPI numbers in January - Drug Topics

ADVERTISEMENT

CMS to require NPI numbers in January
CMS to require NPI numbers in January
Oct 4, 2007
Drug Topics E-News

After a delay of seven months, CMS will insist upon NPI (National Provider Identification) numbers for Medicare billing beginning in January 2008. The requirement for using NPIs was originally slated to begin in May, but delays forced CMS to extend a transition period. Since May, many health plans have required pharmacies to submit both legacy identifiers as well as NPIs to ensure that the claims are paid. CMS announced that its transition period when both NPI and legacy identifiers are required will end at that time.

Click here to see more articles from Drug Topics Daily News.

To go to the Drug Topics homepage, click here.

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

ADVERTISEMENT

Survey
How much trouble do you have dealing with doctors' bad handwriting?
It's a minor inconvenience
It's a problem from time to time
It's a source of ongoing frustration
Don't get me started!
It's a minor inconvenience
9%
It's a problem from time to time
35%
It's a source of ongoing frustration
35%
Don't get me started!
21%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Modern Medicine is a new online resource designed to meet the evolving needs of physicians. It brings together elements from Advanstar's trusted healthcare journals along with powerful tools, resources, decision support and advisory functions.

Source: Drug Topics E-News, 10/4/2007
Click here